The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia

Trial Profile

The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 May 2015

At a glance

  • Drugs Desmopressin (Primary)
  • Indications Nocturia
  • Focus Therapeutic Use
  • Acronyms Nocturia-SMBP
  • Most Recent Events

    • 19 May 2015 Results presented at the 110th Annual Meeting of the American Urological Association.
    • 06 Dec 2013 Planned end date changed from 1 Apr 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov record.
    • 23 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top